Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Pediatr Infect Dis J. 2013 Sep;32(9):e370–e376. doi: 10.1097/INF.0b013e31828e8c09

Figure 1.

Figure 1

Figure 1

Mean change in (A) log10 plasma HIV RNA viral load and (B) CD4+ lymphocyte percentage point from baseline to 48 weeks in the total study cohort after starting a nucleoside reverse transcriptase inhibitor only antiretroviral regimen (NOAR) or highly active antiretroviral therapy(HAART). Error bars indicate standard deviations. The numbers of subjects with available observations at each time (N) are indicated at the bottom of both plots, with the NOAR group on top. LEGACY cohort, 2001-2006.

(A) Note: P-values for weeks 24 and 48 are ≥ 0.05.